Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CD44 | P16070 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9812334 | 0.79 | CA2 (0.44) | GABRA1GABRB2CYP3A4TSHRPIK3CA | |
| SCHEMBL583082 | 0.79 | CYP3A4 (0.39) | CYP3A4TSHRPIK3CANPC1MAPT | |
| SCHEMBL2975923 | 0.78 | CYP3A4 (0.50) | GABRA1GABRB2CYP3A4TSHRPIK3CA | |
| SCHEMBL574123 | 0.77 | ALDH1A1 (0.42) | GABRA1GABRB2TSHRESR1ESR2 | |
| SCHEMBL15950944 | 0.76 | CYP3A4 (0.36) | CYP3A4TSHRPIK3CAALDH1A1CD44 | |
| SCHEMBL2966359 | 0.74 | NPC1 (0.32) | CYP3A4TSHRPIK3CANPC1MAPT | |
| SCHEMBL6386087 | 0.72 | CA2 (0.39) | GABRA1GABRB2TSHRNPC1MAPT | |
| SCHEMBL7765833 | 0.72 | CYP3A4 (0.32) | CYP3A4TSHRPIK3CA | |
| SCHEMBL779788 | 0.71 | MAPK1 (0.41) | TSHRNPC1MAPTRAB9AALDH1A1 | |
| SCHEMBL10608749 | 0.71 | RIPK1 (0.39) | TSHRNPC1RAB9AALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7767625-B2 | Carboxanilides as microbiocides | SYNGENTA CROP PROTECTION, INC. (US) | 2010-08-03 | — | — | US | disclosed |
| US-20080214532-A1 | Carboxanilides as Microbiocides | SYNGENTA CROP PROTECTION, INC. | 2008-09-04 | — | — | US | disclosed |
| EP-1861374-A1 | CARBOXANILIDES AS MICROBIOCIDES | Syngeta Participations AG (CH) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006100039-A1 | CARBOXANILIDES AS MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2006-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214532-A1 | Carboxanilides as Microbiocides | CD14, FPR1, MPO | GABRA1 1715/4885GABRB2 1874/4885CYP3A4 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.